Received: 21 February 2022
Revised: 24 May 2022
Accepted: 31 May 2022
First Online: 23 June 2022
: P.S.P. receives funding for unrelated studies from AstraZeneca and Pfizer, and served as a consultant for Sanofi-Pasteur, Seqirus, and Nestlé Foundation. All other authors report no conflicts of interest.
Free to read: This content has been made available to all.